Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling.
Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling.Utilizing a patent-pending technology to instantly and completely stop the degradation process and maintain sample stability thereafter, Denator aims to become the leading supplier of instruments and consumables that enable scientists to stabilize biological tissues and fluids at the moment of sampling thereby enhancing the quality and value of subsequent analytical results.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 10, 2011 | Series Unknown | $1.70M | 4 | — | — | Detail |
Feb 1, 2007 | Series B | $2.16M | 1 | — | — | Detail |
Apr 20, 2006 | Series A | $664K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Servisen Holding | — | Series Unknown |
Wikow Ventures | — | Series Unknown |
SGP Group | — | Series Unknown |
T-bolaget | — | Series Unknown |